Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.28 M
Marketcap
5,54ย โ‚ฌ
Share price
2.54%
Change (1 day)
-65.09%
Change (1 year)

Cel-Sci (CVM) - Net assets

Net assets on the balance sheet as of June 2025 : โ‚ฌ6.03 Million

According to Cel-Sci 's latest financial reports the company has โ‚ฌ6.03 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cel-Sci - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$โ‚ฌ11.55 M-7.44%
2023-09-30$โ‚ฌ12.48 M-62.03%
2022-09-30$โ‚ฌ32.87 M-32.7%
2021-09-30$โ‚ฌ48.84 M190.34%
2020-09-30$โ‚ฌ16.82 M257.18%
2019-09-30$โ‚ฌ4.7 M596630.71%
2018-09-30$โ‚ฌ0 M-100.03%
2017-09-30$-โ‚ฌ2.85 Million368.99%
2016-09-30$-โ‚ฌ0.61 Million-85.78%
2015-09-30$-โ‚ฌ4.27 Million-151.54%
2014-09-30$โ‚ฌ8.26 M66.94%
2013-09-30$โ‚ฌ4.95 M-9.71%
2012-09-30$โ‚ฌ5.48 M-17.98%
2011-09-30$โ‚ฌ6.68 M-67.29%
2010-09-30$โ‚ฌ20.44 M235.75%
2009-09-30$โ‚ฌ6.09 M-21.22%
2008-09-30$โ‚ฌ7.73 M-24.98%
2007-09-30$โ‚ฌ10.3 M-1501.94%
2006-09-30$-โ‚ฌ0.74 Million-141.96%
2005-09-30$โ‚ฌ1.75 M-47.25%
2004-09-30$โ‚ฌ3.32 M215.13%
2003-09-30$โ‚ฌ1.05 M-2.65%
2002-09-30$โ‚ฌ1.08 M-75.38%
2001-09-30$โ‚ฌ4.39 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Curis
CRIS
-โ‚ฌ12.62 Million-309.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.34 Billion-5,621.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.26 B 136,826.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.53 B 8,801.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ6.23 B 103,160.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ68.09 B 1,128,407.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B 8,191.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ3.06 M-49.18%๐Ÿ‡บ๐Ÿ‡ธ USA